Article Details

AstraZeneca's Imfinzi shows benefits in endometrial cancer trial

Retrieved on: 2024-03-19 17:32:10

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Imfinzi shows benefits in endometrial cancer trial. View article details on HISWAI: https://www.clinicaltrialsarena.com/news/astrazeneca-endometrial-cancer-trial/

Excerpt

AstraZeneca has reported treatment benefits in findings from the DUO-E clinical trial of Imfinzi (durvalumab) plus Lynparza (olaparib).

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up